A Japanese healthcare conglomerate is the lead investor ReCor Medical‘s $15 million Series D round ReCor plans to use to back a U.S. clinical trial of its ultrasound renal denervation device.
(Reuters) — Doctors at a San Francisco hospital began an unusual series of kidney transplants yesterday with 6 living donors providing organs to 6 patients in a chain that began with a woman described as an altruistic donor unrelated to any of the recipients.
Astute Medical said it’s in line to receive up to $30 million under a standing loan agreement from funding partner CRG to commercialize its recently approved NephroCheck kidney-injury test, and could receive an additional $10 million if it hits certain revenue milestones.